Ovo Labs

Ovo Labs invites inquiries about clinical collaboration, team recruitment, and participation in the EmbryoProtect therapeutics validation pipeline.

couples worldwide struggle with infertility

Shugoshin 1 research indicates human eggs may partially reverse age-related chromosome defects. Early findings highlight potential for improved IVF outcomes, though further clinical trials are required before practical application.

Jun 2026Her SerenityNews article

Ovo Labs explores a natural biological pathway to improve egg quality and fertility outcomes. The company’s research targets molecular mechanisms in eggs, aiming to enhance reproductive success without invasive procedures. Early findings suggest potential applications for women facing age-related fertility decline or poor egg quality.

Jan 2026Fertility NewsNews article

Researchers successfully rejuvenate human eggs, marking the first time aging has been reversed in eggs. This development could significantly improve IVF success rates for older women by restoring egg functionality. The technique targets cellular aging mechanisms to enhance fertility potential.

Jan 2026The SunNews article

Ovo Labs demonstrates the first successful rejuvenation of human eggs, offering a potential solution for couples struggling with infertility. The biotech company claims its method could restore egg quality, addressing a major barrier for millions seeking assisted reproduction. Early results suggest the technique may improve outcomes for those facing age-related fertility decline.

Jan 2026bio-m.orgNews article